tirzepatide cardiovascular trial UC Irvine researchers project cardiac benefits from weight-loss medication Tirzepatide and Cardiovascular Outcomes in

Rheological characterization and dissolution kinetics of fibrin gels crosslinked by a microbial transglutaminase

(between East 67 th and East 68 th streets) New York, NY 10065 Take the B elevator to the 6 th floor

Have you ever had your Zepbound arrive warm, or accidentally left it in a hot car

This change in digestive signaling can trigger nausea within the first few weeks of treatment, affecting roughly 25-40% of patients in clinical trials

The antidiabetic medication tirzepatide reduces the risk of heart-failure events in patients with heart failure with preserved ejection fraction and obesity, research suggests

Sci Transl Med 14:eabo3445